The risk factor association syndrome as a barisystemic syndrome: A view on obesity and the metabolic syndrome

Medical Hypotheses

Volumn 68, Issue 3, 2007, Pages 541-545

  Nunes, José Pedro L ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE;

ARTICLE; BARIATRIC SURGERY; BARISYSTEMIC SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; HEREDITY; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; WEIGHT REDUCTION;

BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; OBESITY; RISK FACTORS; SLEEP APNEA SYNDROMES; SYNDROME;

EID: 33845943821     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.08.021     Document Type: Article

References (32)

1. Kannel W.B., Dawber T.R., Kagan A., Revotskie N., and Stokes III J. Factors of risk in the development of coronary heart disease - six year follow-up experience. The Framingham study. Ann Intern Med 55 (1961) 33-50
2. Framingham heart study. 50 Years of research success. Available at: [accessed 16.06.06].
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
4. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 15 (1998) 539-553
5. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 16 (1999) 442-443
6. Einhorn D., Reaven G.M., Cobin R.H., Ford E., Ganda O.P., Handelsman Y., et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 9 (2003) 237-252
7. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Available at: . [accessed 13.06.06].
8. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-52.
9. Carr D.B., Utzschneider K.M., Hull R.L., Kodama K., Retzlaff B.M., Brunzell J.D., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53 (2004) 2087-2094
10. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004 23; 351: 2683-93.
11. O'Brien P.E., Dixon J.B., Laurie C., Skinner S., Proietto J., McNeil J., et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 144 (2006) 625-633
12. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. Jama 292 (2004) 1724-1737
13. Karch F.E., and Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 21 (1977) 247-254
14. Graham T.E., Yang Q., Blüher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354 (2006) 2552-2563
15. Polonsky K.S. Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med 354 (2006) 2596-2598
16. Gelfand E.V., and Cannon C.P. Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors. J Am Coll Cardiol. 47 (2006) 1919-1926
17. Wolk R., and Somers V.K. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab. 8 (2006) 250-260
18. Nunes JPL, Faria MS, Winck JC. Apnea/hypopnea index and benzodiazepine use in patients with arterial hypertension and excessive weight. Int J Cardiol [in press; E pub 2 May 2006].
19. Coughlin S.R., Mawdsley L., Mugarza J.A., Calverley P.M., and Wilding J.P. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 25 (2004) 735-741
20. Lam J.C., Lam B., Lam C.L., Fong D., Wang J.K., Tse H.F., et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir Med. 100 (2006) 980-987
21. Ip M.S., Lam B., Ng M.M., Lam W.K., Tsang K.W., and Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 165 (2002) 670-676
22. Punjabi N.M., Sorkin J.D., Katzel L.I., Goldberg A.P., Schwartz A.R., and Smith P.L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 165 (2002) 677-682
23. Tassone F., Lanfranco F., Gianotti L., Pivetti S., Navone F., Rossetto R., et al. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol. 59 (2003) 374-379
24. Kanagala R., Murali N.S., Friedman P.A., Ammash N.M., Gersh B.J., Ballman K.V., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107 (2003) 2589-2594
25. Gami A.S., Pressman G., Caples S.M., Kanagala R., Gard J.J., Davison D.E., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 110 (2004) 364-367
26. Peker Y., Kraiczi H., Hedner J., Loth S., Johansson A., and Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J. 14 (1999) 179-184
27. Milleron O., Pilliere R., Foucher A., de Roquefeuil F., Aegerter P., Jondeau G., et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J. 25 (2004) 728-734
28. Nunes J.P.L., and Oliveira N.P. Cardiac structure and apnea/hypopnea index in patients with arterial hypertension and excessive weight. Kidney Blood Press Res 29 (2006) 159-164
29. Lavie P. Sleep apnea syndrome: is it a contributing factor to the sex differential in mortality?. Med Hypotheses 21 (1986) 273-276
30. Nunes J.P.L. The case for dietary calcium restriction in patients with atherosclerosis. Med Hypotheses 65 (2005) 521-524
31. Nunes J.P.L. Arterial hypertension and sepsis. Rev Port Cardiol. 22 (2003) 1375-1379
32. von Hafe P., Lopes C., Maciel M.J., and Barros H. Clustering of cardiovascular risk factors in an urban population of Oporto, Portugal. Acta Med Port 11 (1998) 1059-1064